3 results
Approved WMOCompleted
VIKS-2A:To determine the optimal dosage of vitamin K for supplementation to obtain a stable anticoagulation effect.VIKS-2B:To determine whether supplementation with the found optimal dosage of vitamin K from study VIKS-2A will decrease the number of…
Approved WMORecruiting
Primary: To describe safety and tolerability during longer-term administration of AR101 and follow-up observation after the last dose of AR101.Secondary: - To assess the level of desensitization achievable through extended maintenance dosing of…
Approved WMORecruiting
To explore skin adaptation after repeated sub-erythemal UV-dose and individual factors that might underlie this process.